Ilya Petrou, M.D.
Novel preparations manage intertriginous, scalp psoriasis
Intertriginous and scalp psoriasis has always been difficult to treat, mostly due to a lack of patient adherence. Using novel preparations as well as appropriate vehicles can significantly increase patient compliance and lead to improved treatment outcomes, according to one expert.
Making the science behind cosmeceuticals count
The market is flooded with a sea of cosmeceutical products that can help to improve the quality and appearance of patients' skin. Most of the products available today do, in fact, work and are backed by solid science, but they should be part of an ongoing skincare regimen and should not be viewed as a panacea for aging skin.
When choosing the right fillers, knowledge is power
The aesthetic market is inundated with a gamut of fillers, many of which can be used for the same or similar cosmetic indications. But not all fillers are created equal, and a better understanding of the unique features of each individual product can help physicians choose their filler of choice for a given indication.
Systemic medications for psoriasis therapy must be prescribed with caution
New and emerging systemic medications (such as the biologics) can be very useful in the treatment of patients suffering from moderate to severe psoriasis, particularly in those patients recalcitrant to other tried therapies. These potent medications can be associated with severe adverse events (Aes), however, and it is up to the clinician to carefully weigh the pros and cons of each medication before making decisions on therapy.
Emerging botulinum toxins enter the cosmetic market
Ever since Botox Cosmetic (onabotulinumtoxinA, Allergan) hit the market, it has gained enormous popularity in both the cosmetic and medical fields, and many other pharmaceutical and aesthetic companies have tried to produce additional botulinum toxins. Though Botox and Dysport (abobotulinumtoxinA, Medicis) remain the most popular, others are surfacing.
Researchers work to ID gene markers to assess melanoma recurrence
Risk stratification is crucial in helping clinicians identify which melanoma patients would benefit most from adjuvant therapy in the hopes of avoiding tumor recurrence. Though much work still needs to be done, researchers say they are closer to identifying which combination of gene markers can best assess the risk of recurrence in melanoma patients and who should receive adjuvant therapy.
Delivering key messages starts with effective communication
Speaking to a group may appear easy and even second nature to some physicians, but the ability to direct important, memorable messages to different target audiences requires practice. Though they may excel in their medical specialty, many physicians are not natural pedagogues comfortable speaking in front of a group.
Recognizing variants of cellulitis key to effective diagnosis
Usually, cellulitis is a straightforward diagnosis to the dermatologist, but atypical presentations and a list of clinically similar dermatoses mimicking the condition can confuse the clinician and lead to misdiagnosis. Accurately recognizing the variants of cellulitis and its differential diagnoses is crucial to diagnose the condition and prescribe appropriate therapy.
Combo of cryosurgery, imiquimod improves actinic keratoses clearance
A 2010 study shows that the use of Zyclara (imiquimod 3.75 percent, Graceway) following cryosurgery complements the efficacy of cryosurgery in the total reduction and complete clearance of actinic keratoses (AKs).
Gamma Knife procedure an innovative option for treating cerebral metastases
Effectively treating metastatic melanoma remains a challenging task, and this is particularly true when the tumor spreads to the brain. Gamma Knife radiosurgery is one therapeutic modality that can treat metastatic lesions in the brains of carefully selected patients while sparing the surrounding healthy tissue and improving patients' quality of life.

Poll

View Results